The aminothiazolyl-cephalosporin RU 29 246, the active metabolite of the prodrug-ester HR916, is active against strains producing the widespread plasmid-encoded TEM-1, TEM-2and SHV-1 /Mactamases. Except for TEM-7the activity of RU29 246 against strains producing extended broad spectrum 0-lactamases (TEM-3, TEM-5, TEM-6, SHV-2, SHV-4, SHV-5, CMY-1, CTX-M), however, is low. Relative hydrolysis rates of RU29 246 are comparable with those of cefpodoxime, the active metabolite of CS-807, and are extremely low for the TEM-1and SHV-1 jS-lactamases. The compounddemonstrates remarkable inhibitory activity against the chromosomal /Mactamase of Enterobacter cloacae P99. In the presence of 1.7/zm this enzyme loses 50% of its activity. At concentrations of 0.43, 0.003 and 0.01//g/ml the compoundbinds preferentially to the penicillin-binding protein (PBP) 3 of Escherichia coli K12, to the PBPs 2x and 3 of Streptococcus pneumoniae R6 and to PBP 1 of Staphylococcus aureus SG 51 1, respectively.
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RU 29 246 (7-jS-[[2-(2-aminothiazol-4-yl)-2-53;«-oximino]
acetamido]ceph-3-em-3-methoxymethyl-4-carboxylic acid, Fig. 1 ), a new cephem antibiotic, is active against a broad spectrum of clinically important pathogens including manystrains of Staphylococci, Streptococci and Enterobacteriaceae1*.
Stability against /Mactamases is a major parameter for new cephalosporins and the compoundwas therefore further investigated for its stability against various chromosomally-and plasmid-encoded enzymes including extended broad spectrum /Mactamases described recently. In addition, the ability of RU 29 246 to inhibit the activity of/Mactamase was investigated as well as its affinity for penicillin-binding proteins.
Materials and Methods

Antibiotics
RU 29 246 was provided by Hoechst AG, the other compounds (cefpodoxime, cefixime, cefdinir, ceftibuten, cefaclor, cefuroxime and cephaloridine) were obtained from the manufacturers.
Bacterial Strains and Antibiotic Susceptibility Tests
The strains producing the appropriate /Mactamases were Escherichia coli V9458(TEM-1), E. coli
(TEM-6)2), E. coli (TEM-7), E. coli 2141E (SHV-1), K. pneumoniae SH122 (SHV-2)3), K. pneumoniae 197 (SHV-4), K. pneumoniae 160 (SHV-5), K. pneumoniae CHO (CMY-1)4), K. pneumoniae Athen (CMY-2), E. coli GRI (CTX-M)5), Enterobacter cloacae P99, K. pneumoniae 1082E (K-l), and Citrobacterfreundii J20. All strains producing plasmid-encoded /Mactamases were tested by the agar dilution technique using Mueller-Hinton agar (Difco). An inoculum of 104 cfu/spot was delivered by a multipoint-inoculator to agar plates which contained 2-fold antibiotic dilutions. The plates were incubated for 16 hours in ambient air at 35°C. After incubation for 16 hours the MICof each antibiotic was determined. The MIC was defined as the lowest concentration of antibiotic at which no visible growth or growth of< 3 colonies was observed.
Purification of #-Lactamases For the purification of TEM-1, TEM-2, SHV-1, P99, K-l and J20 jS-lactamases, cells were grown in 1 liter Mueller-Hinton broth at 37°C to late logarithmic phase, sedimented at 6,000 x g for 30 minutes and resuspended in 5ml 0.1 m potassium phosphate buffer, pH 7.0. The cell suspensions were sonicated (7 minutes, pulsed 50%) and centrifuged at 15,000 x g for 30 minutes. The crude extracts were applied to Sephacryl S-200 superfine (Pharmacia), the column was eluted with buffer and the enzymes were detected by spectrophotometric measurement with pyridinium-2-azo-/?-dimethylaniline chromophore (PADAC, Calbiochem) as substrate.
For the purification of the TEM-6of CTX-Menzymes, cells were grown in 900 ml of tryptic soy broth for 6 hours at 35°C, sedimented at 6,000 x g for 20 minutes and resuspended in 4.5ml of 1%glycine. The suspensions were sonicated (5 minutes, pulsed 60 -70%) and centrifuged at 15,000 x g for 30 minutes. The supernatants were dialyzed twice for 5 hours against 500 ml of 1 % glycine. Purification of the /Mactamases was achieved by electrofocusing. Approximately 6 ml of the crude enzyme preparations were loaded onto a Multiphor preparative flatbed electrofocusing unit (LKB). Focusing was performed lengthwise at a constant power of 16W(4°C) for 16 hours. Ultradex granulated gel containing 5% ampholytes pH 7 -1 1 (LKB) was used. After 16 hours the gel bed was fractionated in equally large compartments and /Mactamase activity was estimated spectrophotometrically using cefotaxime (CTX-M) or ceftazidime (TEM-6) as substrates. The gel fractions containing the /Mactamases were loaded onto polypropylene columns with nylon nets (0.01 mm)and eluted with 6ml of 0.05M phosphate buffer, pH 7.0.
Stability against /?-Lactamases Hydrolytic stability of RU29 246, cefpodoxime and cefuroxime in the presence of /Mactamases obtained from different bacteria was determined by the spectrophotometric method according to Ross and co-workers6) at 258, 255 and 275 nm, respectively. The time necessary to hydrolyse 50 nmol/ml of antibiotic at 22°C was measured and compared with the hydrolysis time of cephaloridine (255 nm).
Inhibition of /?-Lactamase Activity
In a total volume of 1 ml potassium phosphate buffer (0.1 M, pH 7.0) the reaction mixtures contained 20jum PADACand RU29 246, cefpodoxime or cefuroxime in various concentrations (0.05~500/im). The reactions were started by the addition of appropriate amounts of enzymeand were followed spectrophotometrically at 578 nm and 22°C. The degradation of PADACwithout inhibitor was taken as control and set as 100%.
Affinity for Penicillin-binding Proteins (PBPs)
The binding of RU 29 246 and cefpodoxime to the PBPs of Escherichia coli K12 was determined using [125I]-ampicillin according to Schwarz and co-workers7). The binding to the PBPs of Streptococcus pneumoniae R6 and Staphylococcus aureus SG 511 was determined using [3H]-propionylampicillin as described previously8). Activity of RU29 246 against Strains Producing Extended Broad Spectrum /?-Lactamases RU29 246 was found to be active against strains producing commonplasmid-encoded /Mactamases e.g. TEM-1, TEM-2 or SHV-1 (Table 1) as well as TEM-7 among the more recently discovered enzymes. The MICs of RU29 246 against strains knownto synthesize these enzymes ranged between 0.125 and 0.5 fig/ml. The activity of RU 29 246 against isolates producing other extended broad spectrum /Mactamases is low as is also the case for the majority of the other orally absorbable cephalosporins included in the table. MIC-values of RU29 246 against these isolates ranged between 8 and 1,024/ig/ml.
Relative Stability of RU 29 246 against /?-Lactamases In the presence of all enzymes tested hydrolysis rates of RU29 246 were much lower than those of cephaloridine (relative hydrolysis rate= 100%) and almost equal to those of cefpodoxime ( Table 2 ). RU29 246 was more stable than cefuroxime especially against the cephalosporinases produced by Klebsiella and Citrobacter. Against the TEM-1and SHV-1 enzymes RU29 246 was completely stable, while the plasmid-and chromosomally-encoded extended spectrum enzymes investigated showed some hydrolysis. The relative hydrolysis rates were highest for CTX-Mamong the plasmid-encoded /Mactamases and for the /Mactamase produced by Citrobacter freundii J20 amont the chromosomally-encoded enzymes (both 13%). Relative hydrolysis rate of cephaloridine = 100%. Inhibition of /?-Lactamase Activity As indicated in Table 3 , both RU 29 246 and cefpodoxime did not inhibit the plasmid-encoded TEM-1 enzyme of Escherichia coli and only reduced the activity of the chromosomally-encoded Klebsiella and Citrobacter enzymes by 50% at concentrations > 200 or > 100^m, respectively. High inhibitory activity, however, could be observed with the enzyme of Enterobacter cloacae P99. In the presence of 1.7/iM RU29 246 this enzyme lost 50% of its activity.
Affinity
for PBPs The results of a competition assay with [125I]-ampicillin show that RU29 246 had most affinity for the high molecular weight PBPs in Escherichia coli K12 (Table 4 ). This is in agreement with the results for cefpodoxime and other third generation cephalosporins described in the literature. The primary target was PBP 3 which was 50% saturated at concentrations of 0.43 and 0.17/zg/ml by RU 29 246 and cefpodoxime, respectively. These values correlated well with corresponding MICs (0.4 and 0.2/zg/ml) determined against this strain in Mueller-Hinton broth. At a concentration of 0.69 /xg/ml, RU29 246 saturated 50% of PBPs 1A/B.
In the presence of RU 29 246 (1/2 or 1/4 the MIC) the growth of E. coli K12 was filamentous. As shown in 
Discussion
It is important that a cephalosporin should be stable against /Mactamases. The stability of a compound depends on the type of enzymeto which it is exposed. The chromosomally-encodedenzymesproduced by manyEnterobacteriaceae are active against the majority of cephalosporins. So, the MIC90-values of RU29 246 are equal to or above 128 /ig/ml for Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Serratia marcescens and Serratia liquefaciensl).
It has been shown recently that RU29 246 is highly stable in the presence of a number of common plasmid-encoded enzymes which contributes to the low MIOvalues determined against many of these enzyme producers9). Until recently plasmid-encoded enzymes hydrolyzing third generation cephalosporins were rarely produced by Escherichia coli or Klebsiella spp. Nowa large number of extended broad spectrum /Mactamases have been described10). The stability of RU29 246 and that of other orally absorbable cephalosporins to the novel enzymes is lower than that against the widespread TEM-1 or SHV-1 /Mactamases. Terefore the MIC-values of these compounds are accordingly high for strains producing extended broad spectrum enzymes such as TEM-3, TEM-4, TEM-5, TEM-6, SHV-2, SHV-4, SHV-5, the cephamycinases CMY-1,CMY-2or the new type of cefotaximase CTX-M. RU 29 246 is not an inhibitor for the TEM-1 /Mactamase, but inhibits the chromosomally-encoded enzyme of Enterobacter cloacae P99 at fairly low concentrations. In this respect, its properties are similar to those of other third generation cephalosporins of the cefotaxime-class but differ from recently developed aminothiazol-cephalosporins with quaternary substituents in the 3-position like cefpirome which does not inhibit this enzyme1 X).
The affinity of RU29 246 for the PBPs ofEscherichia coli K12 is very similar to that ofcefpodoxime. The high binding to PBP 3 results in the formation of filaments with subsequent lysis of the cells. The high affinity of the compound to PBP 1 of Staphylococcus aureus SG 511 might be one of the reasons for its high antibacterial activity against Staphylococci1) which is a desirable property for a new oral cephalosporin.
